Changes in hemophilia A therapy – an analysis of real-world data from smart medication eDiary over the past 10 years

Published abstract for GTH 2023 (67th Annual Meeting of the Society of Thrombosis and Haemostasis Research):

A. Rösch, D. Schmoldt, W. Mondorf

Hämostaseologie 2023; 43(S1): S57–S58

The analysis of real-world data from ten years of smart medication eDiary – more than 1,500 patients from over 45 treatment centers – shows the shift in hemophilia A therapy toward extended half-life (EHL) products and monoclonal antibodies.

The abstract is available here (DOI 10.1055/s-0042-1760548), opens in a new tab.